Oncolytics Biotech Inc.
Oncolytics Biotech® Inc. is conducting clinical trials in the U.S. and the U.K. with the objective of developing REOLYSIN® as a human cancer therapeutic
| Name: | Brad Thompson |
Company: | Oncolytics Biotech Inc. |
Website: | www.oncolyticsbiotech.com |
| Position: | CEO |
Sector: | Biotech / Pharma |
Stock: | |